Showing results (141-150 of 216) with videos related to

Sort By:
Pageof 22
Cancer Control : Journal of the Moffitt Cancer Center|January 2, 2023
Pretreatment Serum Lactate Dehydrogenase and Metastases Numbers as Potential Determinants of Anti-PD-1 Therapy Outcome in Nasopharyngeal CarcinomaWael A S Ali, Xinxin Huang, Yuehan Wu, et al.
Theranostics|March 21, 2018
Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular CarcinomaHongyun Zhao, Meng Wu, Leilei Zhu, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 2014
An investigation of symptom burden and quality of life in Chinese chemo-naïve advanced lung cancer patients by using the Instrument-Cloud QOL SystemYuxiang Ma, Yunpeng Yang, Yan Huang, et al.
NPJ Precision Oncology|March 6, 2024
Remodeling the tumor-immune microenvironment by anti-CTLA4 blockade enhanced subsequent anti-PD-1 efficacy in advanced nasopharyngeal carcinomaYuxiang Ma, Huaqiang Zhou, Fan Luo, et al.
Medcomm|April 30, 2024
Phase 1b trial of anti-HER2 antibody inetetamab and pan-HER inhibitor pyrotinib in HER2-positive advanced lung cancerYihua Huang, Yuanyuan Zhao, Yan Huang, et al.
Journal for Immunotherapy of Cancer|March 19, 2021
Copy number loss in granzyme genes confers resistance to immune checkpoint inhibitor in nasopharyngeal carcinomaYuxiang Ma, Xi Chen, Ao Wang, et al.
Signal Transduction and Targeted Therapy|January 28, 2024
QL1706 (anti-PD-1 IgG4/CTLA-4 antibody) plus chemotherapy with or without bevacizumab in advanced non-small cell lung cancer: a multi-cohort, phase II studyYan Huang, Yunpeng Yang, Yuanyuan Zhao, et al.
Translational Lung Cancer Research|October 21, 2024
Molecular subtypes and prognostic factors of lung large cell neuroendocrine carcinomaTingting Liu, Xueyuan Chen, Silang Mo, et al.
Molecular Cancer Therapeutics|August 31, 2016
AC0010, an Irreversible EGFR Inhibitor Selectively Targeting Mutated EGFR and Overcoming T790M-Induced Resistance in Animal Models and Lung Cancer PatientsXiao Xu, Long Mao, Wanhong Xu, et al.
Translational Oncology|November 22, 2020
Establishment and application of a predictive model for gefitinib-induced severe rash based on pharmacometabolomic profiling and polymorphisms of transporters in non-small cell lung cancerShaoxing Guan, Xi Chen, Shuang Xin, et al.
Pageof 22